Ketamine, MDMA, DMT and Psilocybin: A Closer Look at Four Psychedelics

Listicle

Published: September 29, 2021

Ruairi J Mackenzie

Ketamine, MDMA, DMT and Psilocybin: A Closer Look at Four Psychedelics content piece image

Ketamine, MDMA, DMT and psilocybin are four psychedelics that are making waves in psychiatric medicine. While they are all banned or restricted in the industrialized west, these compounds have moved past decades of stigma to become well-studied therapeutics either approved or in trial to treat mental health conditions such as major depression and post-traumatic stress disorder.

Download this listicle to learn:

The backgrounds of these psychedelics
Their properties and potential mechanisms of action
The conditions that they could help treat

Meet the Author

Ruairi J Mackenzie

RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.